- Home
- BAX vs NCLH Comparison
BAX vs NCLH Comparison
Compare BAX & NCLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAX
- NCLH
- Stock Information
- Founded
- BAX 1931
- NCLH 1966
- Country
- BAX United States
- NCLH United States
- Employees
- BAX N/A
- NCLH N/A
- Industry
- BAX Medical/Dental Instruments
- NCLH Marine Transportation
- Sector
- BAX Health Care
- NCLH Consumer Discretionary
- Exchange
- BAX Nasdaq
- NCLH Nasdaq
- Market Cap
- BAX 12.4B
- NCLH 11.5B
- IPO Year
- BAX N/A
- NCLH 2013
- Fundamental
- Price
- BAX $23.99
- NCLH $26.66
- Analyst Decision
- BAX Hold
- NCLH Buy
- Analyst Count
- BAX 9
- NCLH 19
- Target Price
- BAX $32.00
- NCLH $28.33
- AVG Volume (30 Days)
- BAX 6.3M
- NCLH 16.2M
- Earning Date
- BAX 11-07-2025
- NCLH 10-30-2025
- Dividend Yield
- BAX 2.83%
- NCLH N/A
- EPS Growth
- BAX N/A
- NCLH 61.59
- EPS
- BAX N/A
- NCLH 1.54
- Revenue
- BAX $10,887,000,000.00
- NCLH $9,560,994,000.00
- Revenue This Year
- BAX $7.38
- NCLH $8.20
- Revenue Next Year
- BAX $3.78
- NCLH $10.43
- P/E Ratio
- BAX N/A
- NCLH $17.46
- Revenue Growth
- BAX 3.60
- NCLH 5.22
- 52 Week Low
- BAX $21.33
- NCLH $14.21
- 52 Week High
- BAX $40.49
- NCLH $29.29
- Technical
- Relative Strength Index (RSI)
- BAX 44.82
- NCLH 62.92
- Support Level
- BAX $23.90
- NCLH $24.36
- Resistance Level
- BAX $24.63
- NCLH $26.28
- Average True Range (ATR)
- BAX 0.58
- NCLH 0.81
- MACD
- BAX 0.13
- NCLH 0.11
- Stochastic Oscillator
- BAX 54.06
- NCLH 83.90
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
About NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 38,400 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.